Literature DB >> 9777041

Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).

L L Judd1, R C Kessler, M P Paulus, P V Zeller, H U Wittchen, J L Kunovac.   

Abstract

Generalized anxiety disorder (GAD) is a relatively common mental disorder in the general population, afflicting approximately 3% of community residents during their lifetime. It is not a benign condition, since significantly increased disability and dysfunction are found in GAD subjects compared to non-GAD subjects. For decades GAD has frequently been observed in the context of other mental and substance abuse disorders. Initially the weight of clinical opinion indicated that GAD was a residual disease which should only be diagnosed when other mental disorders are not present. More recently there has been a growing recognition that comorbidity is a fundamental characteristic of the course and nature of GAD. In a series of secondary analyses conducted in subjects in the National Comorbidity Study database, we found that 8 out of 10 subjects with lifetime GAD also had a comorbid mood disorder during their lifetime. We found unipolar disorders to be four times more common in GAD than bipolar disorders (67% vs. 17%), providing indirect support for the previously reported observation that GAD and major depression may share a common genetic diathesis. In addition, our analyses support the conclusion that when comorbid mood disorders are present in GAD, a significant increase in associated disability and dysfunction is also found. Thus this comorbid relationship has important implications for clinical course and outcome.

Entities:  

Mesh:

Year:  1998        PMID: 9777041     DOI: 10.1111/j.1600-0447.1998.tb05960.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  45 in total

Review 1.  Anxiety disorder.

Authors:  C Gale; M Oakley-Browne
Journal:  BMJ       Date:  2000-11-11

2.  Diagnostic comorbidity in adults with generalized anxiety disorder: impact of comorbidity on psychotherapy outcome and impact of psychotherapy on comorbid diagnoses.

Authors:  Michelle G Newman; Amy Przeworski; Aaron J Fisher; Thomas D Borkovec
Journal:  Behav Ther       Date:  2009-06-08

3.  Time to response in generalized anxiety disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.

Authors:  Mark Hyman Rapaport; Steve B Skarky; David J Katzelnick; Jeffrey N Dewester; James M Harper; Kay E McCrary
Journal:  Psychiatry (Edgmont)       Date:  2006-12

Review 4.  Stress and health: psychological, behavioral, and biological determinants.

Authors:  Neil Schneiderman; Gail Ironson; Scott D Siegel
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 5.  Current considerations in the treatment of generalized anxiety disorder.

Authors:  Martin A Katzman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

6.  [Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings].

Authors:  Antoni Sicras-Mainar; Milagrosa Blanca-Tamayo; Ruth Navarro-Artieda; Javier Rejas-Gutiérrez
Journal:  Aten Primaria       Date:  2009-02-03       Impact factor: 1.137

Review 7.  Worry and generalized anxiety disorder: a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment.

Authors:  Michelle G Newman; Sandra J Llera; Thane M Erickson; Amy Przeworski; Louis G Castonguay
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

8.  Protocol for a randomised controlled trial investigating the effectiveness of an online e health application for the prevention of Generalised Anxiety Disorder.

Authors:  Helen Christensen; Kathleen M Griffiths; Andrew J Mackinnon; Kanupriya Kalia; Philip J Batterham; Justin Kenardy; Claire Eagleson; Kylie Bennett
Journal:  BMC Psychiatry       Date:  2010-03-21       Impact factor: 3.630

9.  Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder.

Authors:  Helen Christensen; Adam J Guastella; Andrew J Mackinnon; Kathleen M Griffiths; Claire Eagleson; Philip J Batterham; Kanupriya Kalia; Justin Kenardy; Kylie Bennett; Ian B Hickie
Journal:  Trials       Date:  2010-04-30       Impact factor: 2.279

10.  Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool.

Authors:  Javier García-Campayo; Enric Zamorano; Miguel A Ruiz; Antonio Pardo; María Pérez-Páramo; Vanessa López-Gómez; Olga Freire; Javier Rejas
Journal:  Health Qual Life Outcomes       Date:  2010-01-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.